Healthcare systems worldwide are facing unprecedented pressure, from the rise in chronic diseases and aging populations to fragmented healthcare and over-stretched resources. The result? Delayed, ...
Electronic health records (EHRs); insurance claims; patient registries; wearable tech: Never before has health data been so abundant. However, the United States continues to struggle with siloed ...
The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.
This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...
Panelists discuss how future RWE should expand to include survival, quality of life, and safety data to improve third-line mCRC care. Panelists identify gaps in current evidence and the need for more ...
Real-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design, support regulatory submissions, and demonstrate real-world value. From generating ...
The European Medicines Agency (EMA) uses Data Analysis and Real-World Interrogation Network (DARWIN EU), a data network that became fully operational in 2024, to generate real-world evidence on ...
Generating high-validity real-world evidence requires more than access to data—it demands rigorous methods, thoughtful variable definition, and a deep understanding of clinical context. Join us for ...
The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results